Literature DB >> 26161144

The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer.

Jim N Rose1, Juanita M Crook2.   

Abstract

In the setting of castrate-resistant prostate cancer, patients present with a variety of symptoms, including bone metastases, spinal cord compression and advanced pelvic disease. Fortunately, a variety of radiotherapeutic options exist for palliation. This article focuses on these options, including both external beam radiotherapy and radiopharmaceuticals.

Entities:  

Keywords:  bone metastases; hemi-body radiotherapy; palliative radiotherapy; prostate cancer; radiopharmaceuticals; radium 223

Year:  2015        PMID： 26161144      PMCID： PMC4485416          DOI： 10.1177/1756287215576647

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN： 1756-2872


  110 in total

1.  Surgical resection in metastatic spinal cord compression.

Authors:  Marcus Koch; Jacques De Keyser
Journal:  Lancet       Date:  2006-01-14       Impact factor: 79.321

2.  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.

Authors:  William F Hartsell; Charles B Scott; Deborah Watkins Bruner; Charles W Scarantino; Robert A Ivker; Mack Roach; John H Suh; William F Demas; Benjamin Movsas; Ivy A Petersen; Andre A Konski; Charles S Cleeland; Nora A Janjan; Michelle DeSilvio
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

3.  Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis.

Authors:  Marsha L Haley; Peter C Gerszten; Dwight E Heron; Yue-Fang Chang; Dave S Atteberry; Steven A Burton
Journal:  J Neurosurg Spine       Date:  2011-02-11

4.  Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.

Authors:  F Kraeber-Bodéré; L Campion; C Rousseau; S Bourdin; J F Chatal; I Resche
Journal:  Eur J Nucl Med       Date:  2000-10

5.  Radiotherapeutic management of osseous metastases: a survey of current patterns of care.

Authors:  E Ben-Josef; F Shamsa; A O Williams; A T Porter
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-01       Impact factor: 7.038

6.  Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer.

Authors:  Donald S Crain; Christopher L Amling; Christopher J Kane
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

7.  Effect of rest interval on tumor and normal tissue response--a report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502)

Authors:  W J Spanos; C A Perez; S Marcus; C A Poulter; R L Doggett; A D Steinfeld; P W Grigsby
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-02-15       Impact factor: 7.038

Review 8.  Palliative radiotherapy trials for bone metastases: a systematic review.

Authors:  Edward Chow; Kristin Harris; Grace Fan; May Tsao; Wai M Sze
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

9.  International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?

Authors:  Alysa Fairchild; Elizabeth Barnes; Sunita Ghosh; Edgar Ben-Josef; Daniel Roos; William Hartsell; Tanya Holt; Jackson Wu; Nora Janjan; Edward Chow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-21       Impact factor: 7.038

10.  Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer.

Authors:  S L Turner; S Gruenewald; N Spry; V Gebski
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640
View more
  7 in total

1.  Non-oncologist Physician Knowledge of Radiation Therapy at an Urban Community Hospital.

Authors:  Evan Siau; Hernando Salazar; Jonathan Livergant; Jonathan Klein
Journal:  J Cancer Educ       Date:  2021-02       Impact factor: 2.037

2.  miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer.

Authors:  Ju Guo; Zewen Xiao; Xingwei Yu; Runfu Cao
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

Review 3.  Radium-223 dichloride in clinical practice: a review.

Authors:  Luigia Florimonte; Luca Dellavedova; Lorenzo Stefano Maffioli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-28       Impact factor: 9.236

4.  Development of 131I-ixolaris as a theranostic agent: metastatic melanoma preclinical studies.

Authors:  Thiago Barboza; Tainá Gomes; Priscylla da Costa Medeiros; Isalira Peroba Ramos; Ivo Francischetti; Robson Q Monteiro; Bianca Gutfilen; Sergio Augusto Lopes de Souza
Journal:  Clin Exp Metastasis       Date:  2020-05-11       Impact factor: 5.150

5.  MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma.

Authors:  Yi Fu; Fuhua Cao
Journal:  Onco Targets Ther       Date:  2015-12-17       Impact factor: 4.147

6.  Assessment of Radiation Induced Therapeutic Effect and Cytotoxicity in Cancer Patients Based on Transcriptomic Profiling.

Authors:  Sajjad Karim; Zeenat Mirza; Adeel G Chaudhary; Adel M Abuzenadah; Mamdooh Gari; Mohammed H Al-Qahtani
Journal:  Int J Mol Sci       Date:  2016-02-19       Impact factor: 5.923

Review 7.  Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer.

Authors:  Miriam Hegemann; Moritz Maas; Steffen Rausch; Simon Walz; Jens Bedke; Arnulf Stenzl; Tilman Todenhöfer
Journal:  Asian J Androl       Date:  2017-12-29       Impact factor: 3.285
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.